November 28, 2022

Meeting face-to-face with this vital group to share knowledge and collaborate is an example of Commonwealth Medicine’s commitment to supporting Medicaid Pharmacy teams in their service to members.

September 06, 2022

Does your health care organization have clearly defined goals and metrics? Do teams and employees feel connected to these goals? Do they understand the impact they have on the metrics? If you answered "no" to any of these questions, you may have an opportunity to enhance your organization's strategic planning.

July 18, 2022

Cell and gene-based therapies (CGTs) have captured our imagination for their potential to cure disease after a single course of therapy but have also raised eyebrows for their astronomical price tags.

June 17, 2022

A new Centers for Medicare & Medicaid Services (CMS) rule, effective July 1, 2022, will offer Medicaid patients access to needed therapies while providing options to engage in payment arrangements – value-based purchasing (VBP) – that allow flexibility for states, including the potential to o

June 07, 2022

What percentage of your health care organization’s employees is directly contributing to projects or initiatives aligned with company strategy?

April 01, 2022

For decades, Massachusetts has been an innovative leader in developing behavioral health programs and policies and implemented various statewide provider consultation programs aimed at addressing specific behavioral health (BH) conditions.

March 01, 2022

The generosity of the nearly 720,000 social workers in America is being recognized this month with the theme "The Time is Right for Social Work." The theme underscores the positive contributions so

February 03, 2022

“Sticks and stones may break my bones, but words will never hurt me.”

January 26, 2022

Diversity is not just nice to have in business – it is imperative to drive innovation, deliver relevant products and services that resonate with customers, and enhance corporate culture and productivity.

September 08, 2021

Millions of people suffer from debilitating and potentially deadly health conditions, with limited (if any) treatment options available to them. The Accelerated Approval Pathway (AAP) offers patients access to promising, yet unproven, treatments in a timely manner. The question remains: Is it fulfilling its potential?